Exploring Immune Effects of Oral Insulin in Relatives at Risk for Type 1 Diabetes Mellitus Save

Date Added
December 16th, 2015
PRO Number
Pro00050240
Researcher
Sandra Weber
Keywords
Diabetes
Summary

This is a 2-arm, multicenter, randomized, open-labelled clinical research study. Participants will receive varying doses and schedules of recombinant human insulin in capsules (referred to hereafter as oral insulin). In this design, each participant is randomly assigned to 1 of 2 treatment regimens with equal probability. The primary outcome is the change in immunologic parameters before and after treatment.

Institution
Greenville
Recruitment Contact
Shirley Parker
864-455-3261
sparker@ghs.org

Change_preferences

-- OR --

Create_login